Thrombosis is an important manifestation of the antiphospholipid syndrome (APS). The
thrombin generation (TG) test is a global hemostasis assay, and increased TG is associated …

Abstract Antiphospholipid (antibody) syndrome (APS) is a prothrombotic condition with
increased risk for thrombosis and pregnancy-related morbidity. In addition to clinical criteria …

Background Improving harmonization of the clinical interpretation of anticardiolipin (aCL)
and anti-β2-glycoprotein I antibodies (aβ2GPI) IgG/IgM in the diagnosis of antiphospholipid …

Lupus anticoagulants (LAs) are antiphospholipid antibodies that interfere with in vitro
phospholipid-dependent clotting tests, but are associated in vivo with significant clinical …

Antiphospholipid syndrome is characterized by the presence of antiphospholipid antibodies,
specifically lupus anticoagulant, anticardiolipin antibodies, and anti-β2 glycoprotein-I …

The antiphospholipid syndrome (APS) is characterized by venous or arterial thrombosis
and/or pregnancy morbidity in patients with persistent presence of antiphospholipid …

The diagnostic or test-performance process, as associated to the evaluation or diagnosis of
hemostasis and thrombosis and related disorders, is influenced or controlled by the activity …

Essentials• Limited data are available of freeze‐thaw effect on anticardiolipin and anti‐beta2‐
glycoprotein I antibodies.• Patient samples with antibody titer over a broad range were …

This issue of Clinical Chemistry and Laboratory Medicine includes a report by Pradella and
colleagues regarding a cooperative multicentre study to define the upper limits of normal for …

Antiphospholipid syndrome (APS) is a systemic, autoimmune disorder characterized by the
presence of antiphospholipid antibodies (APLA) directed to various plasma proteins bound …